Ivermectin for communicable diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Nov 2020: Trial started, NCT04834115
  2. 6 Apr 2021: Trial registered, NCT04834115

The trials

NCT04834115: Efficacy of Ivermectin in Outpatients With Non-severe COVID-19

State
State not given
Phase
Phase 3
People
400 planned
Started
17 Nov 2020
Primary completion
30 Apr 2021
Arms
Ivermectin
Results
None posted
  1. 17 Nov 2020: Trial started
  2. 6 Apr 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Acarexx, Bimectin, Bovinet, Cardomec, CARDOTEK 30, Cevamec, Equimec, Eqvalan, Heartgard, Hyvermectin, Ivectin, IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care., Ivertin, Ivomec, Ivosint, Ivermectin (IVM), Ivermectin 0.4mg/kg/day for 5 days, Ivermectin 3 MG, Ivermectin 3mg Tab, Ivermectin Injectable Product, Ivermectin Oral Product, Ivermectin Pill, Ivermectin Tablets, Ivermectin Topical, Ivermectin nasal, Ivermectin oral, Jetamec, Mectizan, Noramectin, Noromectin, Oramec, Pandex, Phoenectin, Sklice, Soolantra, Stromectol, Uvemec, Vermic, Vetmec, Zimecterin, intranasal ivermectin spray.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.